RecruitingNot ApplicableNCT06507930

The COMPASSION Study

The COMPASSION Study: Applying Telehealth to Innovate and Strengthen Connections for Patients With Metastatic Breast Cancer Receiving Hospice Care


Sponsor

Dana-Farber Cancer Institute

Enrollment

200 participants

Start Date

Sep 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

The COMPASSION Study is designed to help women with advanced, inoperable breast cancer who have been referred to home hospice care. It focuses on providing compassionate, personalized support during this time, studying how this care affects quality of life and the experience of both patients and their families. **You may be eligible if...** - You have been diagnosed with advanced (unresectable or metastatic) breast cancer - You have been referred to in-home hospice services and are starting hospice within about one week - You are able to participate in video or phone check-ins - Your hospice care is based in Massachusetts - You are willing to complete a survey at 4 to 6 weeks if you are feeling well enough **You may NOT be eligible if...** - You are not in the Massachusetts area for hospice services - You are unable to provide verbal consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTelehealth Hospice Visits

Telehealth check-in appointments with oncology care team, MD, PA, NP, or hospice nurse, via HIPAA compliant telehealth platform, Zoom, or by phone call.


Locations(1)

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06507930


Related Trials